Sigma Planning Corp’s Palvella Therapeutics PVLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,500	Closed	-$680K	–	1420
2025 Q4	$680K	Buy	+6,500	New	+$554K	0.02%	683
2023 Q3	–	Sell	-326	Closed	-$4.32K	–	1310
2023 Q2	$4.32K	Sell	326 -4,055	-93%	-$246K	﹤0.01%	1198
2023 Q1	$342K	Buy	4,381 +82	+2%	+$9.5K	0.01%	953
2022 Q4	$358K	Buy	4,299 +354	+9%	+$28.4K	0.01%	895
2022 Q3	$363K	Buy	3,945 +3	+0.1%	+$387	0.01%	870
2022 Q2	$590K	Sell	3,942 -568	-13%	-$104K	0.02%	692
2022 Q1	$1.09M	Buy	4,510 +20	+0.4%	+$5.26K	0.03%	501
2021 Q4	$1.36M	Sell	4,490 -66	-1%	-$21.1K	0.04%	429
2021 Q3	$1.88M	Buy	4,556 +58	+1%	+$20.2K	0.06%	344
2021 Q2	$1.38M	Buy	4,498 +1,553	+53%	+$341K	0.04%	441
2021 Q1	$605K	Buy	2,945 +46	+2%	+$10.1K	0.02%	694
2020 Q4	$580K	Buy	2,899 +136	+5%	+$28.3K	0.02%	641
2020 Q3	$457K	Buy	2,763 +494	+22%	+$112K	0.02%	638
2020 Q2	$563K	Buy	2,269 +1,085	+92%	+$254K	0.02%	554
2020 Q1	$216K	Buy	+1,184	New	+$298K	0.01%	758